Dear Valued Stakeholders,
It is my pleasure to present the highlights of our company's progress for the 2024-2025
period. We are excited to share that our company is experiencing significant expansion
across various sectors of the medical field. Initially focused on wound dressing,
intravenous solutions, and haemodialysis, we have now broadened our scope to include
ophthalmology, radiology, critical care, and cardiology products.
Our vision is to become a comprehensive service provider across the entire spectrum of
the medical industry. Looking to the future, we aim to establish our own dialysis centres,
hospitals, and a network of healthcare facilities. This expansion will not only support
our marketing efforts but also enhance our ability to deliver high-quality medical care
equipment and services in all fields of human treatment.
We are actively involved in manufacturing medical equipment and maintaining a close
relationship with the medical community. This collaboration is crucial for refining our
products and boosting sales. I am pleased to report that our focus on cost reduction has
led to increased profitability. Moving forward, we are dedicated to further expanding our
product portfolio and achieving substantial profits that will benefit our shareholders and
investors.
A key component of our strategy is to realize our vision of localized manufacturing in
India. This initiative will support the "Make in India" campaign, enabling us to
export products globally. Currently, we import components from JMS Company Limited in
Japan and Singapore. We have established technical collaborations with these partners and
are transitioning to manufacturing their products in India, which will enhance our global
presence and generate foreign exchange by exporting these products to JMS Japan.
We anticipate robust growth in both company valuation and market presence.
Additionally, our new factory in Aurangabad, recently renamed Sambhaji Nagar, Maharashtra,
will generate substantial business and profit in the coming year. Setting up a factory in
Sambhaji Nagar, Maharashtra, offers several advantages, such as the availability of
skilled manpower due to the presence of several medical, engineering, and IT colleges. The
location is now connected to Mumbai via the Samruddhi Mahamarg, reducing travel time to
within four hours. The government also offers an 80% subsidy on the project, which will
help bring down costs and improve profitability.
In conclusion, our ambitious expansion plans and strategic initiatives are designed to
position us for significant growth and long-term success. As we move forward, our
commitment to innovation, cost-efficiency, and global outreach will drive our efforts to
deliver exceptional value. We deeply appreciate your continued support and confidence in
our vision. Together, we look forward to a future of shared success and prosperity.
Hanskumar Shamji Shah Chairman & Managing Director